Completed
GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1)
NCT02528357
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- GSK Investigational Site Boston, Massachusetts, United States
- GSK Investigational Site New York, United States
- GSK Investigational Site New York, United States
- GSK Investigational Site Nashville, Tennessee, United States